SeaCrest Wealth Management’s Exact Sciences EXAS Stock Holding History

SeaCrest Wealth Management’s Portfolio EXAS Stock Details EXAS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q2	–	Sell	-1,780	Closed	-$235K	–	699
2021 Q1	$235K	Sell	1,780 -263	-13%	-$36K	0.03%	543
2020 Q4	$271K	Sell	2,043 -1,851	-48%	-$224K	0.04%	462
2020 Q3	$397K	Buy	+3,894	New	+$336K	0.06%	306
2020 Q1	–	Sell	-2,789	Closed	-$258K	–	527
2019 Q4	$258K	Sell	2,789 -1,595	-36%	-$140K	0.04%	438
2019 Q3	$396K	Buy	4,384 +1,384	+46%	+$158K	0.07%	321
2019 Q2	$354K	Sell	3,000 -300	-9%	-$30.2K	0.07%	342
2019 Q1	$286K	Buy	3,300 +1,950	+144%	+$166K	0.05%	373
2018 Q4	$85K	Buy	1,350 +350	+35%	+$24K	0.02%	718
2018 Q3	$79K	Buy	1,000 +600	+150%	+$39.1K	0.01%	836
2018 Q2	$24K	Buy	+400	New	+$21.5K	﹤0.01%	1284

Other funds holding EXAS

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

AIM

ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $154B AUM 29.96% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

SeaCrest Wealth Management's EXAS Position: Q2 2021 in Review

SeaCrest Wealth Management sold out of Exact Sciences (EXAS) in Q2 2021, closing a stake of 1,780 shares — an estimated $235K sold.

SeaCrest Wealth Management first reported a position in EXAS in Q2 2018 and held it in 10 quarters. The position peaked at $397K in Q3 2020. 623 funds tracked by Wall St. Rank hold EXAS as of Q2 2021.

SeaCrest Wealth Management reported no remaining Exact Sciences position as of Q2 2021 after selling out during the quarter.
SeaCrest Wealth Management sold 1,780 Exact Sciences shares in Q2 2021, an estimated $235K.
SeaCrest Wealth Management first reported a position in Exact Sciences in Q2 2018 and held it in 10 quarters.
SeaCrest Wealth Management's Exact Sciences position peaked at $397K in Q3 2020.
623 funds tracked by Wall St. Rank held Exact Sciences as of Q2 2021.

Based on SeaCrest Wealth Management's 13F filing for Q2 2021, filed 12 Aug 2021.